Recent advances in nanocarrier‐loaded gels: Which drug delivery technologies against which diseases?

@article{Pitorre2017RecentAI,
  title={Recent advances in nanocarrier‐loaded gels: Which drug delivery technologies against which diseases?},
  author={Marion Pitorre and Henri Gond{\'e} and Clotilde Haury and Marwa Messous and J{\'e}r{\'e}mie Poilane and David Boudaud and Erdem Kanber and Glenn Alexis Rossemond Ndombina and Jean-Pierre Benoit and Guillaume Bastiat},
  journal={Journal of Controlled Release},
  year={2017},
  volume={266},
  pages={140–155}
}
  • Marion Pitorre, Henri Gondé, +7 authors Guillaume Bastiat
  • Published in
    Journal of controlled release…
    2017
  • Medicine, Chemistry
  • ABSTRACT The combination of pharmaceutical technologies can be a wise choice for developing innovative therapeutic strategies. The association of nanocarriers and gels provides new therapeutic possibilities due to the combined properties of the two technologies. Gels support the nanocarriers, localize their administration to the target tissue, and sustain their release. In addition to the properties afforded by the gel, nanocarriers can provide additional drug sustained release or different… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    3
    Twitter Mentions

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 10 CITATIONS

    Biological response and cytotoxicity induced by lipid nanocapsules

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Research progress of in-situ gelling ophthalmic drug delivery system

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 109 REFERENCES

    Combinatorial development of hydrogels that mitigate the foreign body response in primates

    • A. Vegas, O. Veiseh, +31 authors D. Anderson
    • Nat. Biotechnol. 34 (3) (2016) 345–352. M. Pitorre et al. Journal of Controlled Release 266
    • 2017
    VIEW 1 EXCERPT

    Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection

    VIEW 2 EXCERPTS

    Safety

    • J. O'Loughlin, I. Y. Millwood, +3 authors J. R. Paull
    • tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study, Sex. Transm. Dis. 37 (2) (2010) 100–104. M. Pitorre et al. Journal of Controlled Release 266
    • 2017
    VIEW 1 EXCERPT

    Advancing biomaterials of human origin for tissue engineering.

    VIEW 1 EXCERPT